Candel Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Candel Therapeutics's estimated annual revenue is currently $15.3M per year.
- Candel Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Candel Therapeutics has 99 Employees.
- Candel Therapeutics grew their employee count by 10% last year.
Candel Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Development Leader | Reveal Email/Phone |
2 | VP, Clinical Research & Pharmacovigilance | Reveal Email/Phone |
3 | VP Quality | Reveal Email/Phone |
4 | SVP, Regulatory Affairs and Pharmacovigilance Operations | Reveal Email/Phone |
5 | VP Finance and Corporate Controller | Reveal Email/Phone |
6 | VP, Business and Clinical Operations | Reveal Email/Phone |
7 | VP, Viral Vector Process & Analytical Development | Reveal Email/Phone |
8 | Chief Regulatory Officer | Reveal Email/Phone |
9 | Associate Director Clinical Research | Reveal Email/Phone |
10 | Director IT | Reveal Email/Phone |
Candel Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Candel Therapeutics?
Located in Needham, MA, Candel is committed to saving, extending, and improving the lives of cancer patients through oncolytic viral immunotherapies. Our therapies are designed to elicit a broad, potent immune response against solid tumors and their metastases, helping to modulate and tip the balance in favor of the immune system. Our precisely delivered, systemic therapies are intended to substantially improve survival and quality of life throughout all stages of disease. For more information, visit www.candeltx.com or contact us at info@candeltx.com.
keywords:N/A
N/A
Total Funding
99
Number of Employees
$15.3M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Candel Therapeutics News
This is a summary of recent ratings and price targets for Sutro Biopharma and Candel Therapeutics, as provided by MarketBeat. Sell Ratings, Hold...
Candel Therapeutics (NASDAQ:CADL) and Cabaletta Bio (NASDAQ:CABA) Critical Review. Posted by admin on Apr 14th, 2022.
Candel is a late clinical stage biopharmaceutical company focused on helping patients fight cancer with oncolytic viral immunotherapies.
NEEDHAM, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Nasdaq: CADL), a late clinical stage biopharmaceutical company developing novel oncolytic viral immunotherapies, today announced its participation in upcoming medical and scientific conferences. Candel President and Chi ...
NEEDHAM, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Nasdaq: CADL), a late clinical stage biopharmaceutical company developing novel oncolytic viral immunotherapies, today announced that data on patient-reported tolerability assessment of intraprostatic injections will be ...
Other Companies in Needham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.5M | 100 | 22% | N/A |
#2 | $21M | 100 | -1% | N/A |
#3 | $17.7M | 101 | 4% | N/A |
#4 | $23.2M | 102 | 9% | N/A |
#5 | $25.3M | 104 | 2% | N/A |